The latest update is out from HeraMED Ltd. ( (AU:HMD) ).
HeraMED Limited announced its participation in the NWR Virtual Healthcare Conference, where CEO Anoushka Gungadin will present the company’s advancements in digital maternity care. This presentation underscores HeraMED’s commitment to revolutionizing the maternity care industry and highlights its strategic efforts to engage with stakeholders and investors, potentially enhancing its market position and influence in the healthcare sector.
More about HeraMED Ltd.
HeraMED Limited is an innovative medical data and technology company that is transforming maternity care through its hybrid maternity care platform. The company offers a proprietary platform that integrates hardware and software, including the clinically validated HeraBEAT monitor, to enhance the prenatal and postpartum experience. HeraMED’s HeraCARE ecosystem is designed to improve maternal health care by engaging expectant mothers, supporting healthcare professionals, and enabling early risk detection and prevention.
YTD Price Performance: 10.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €7.13M
For detailed information about HMD stock, go to TipRanks’ Stock Analysis page.